Ying-Nan Wang
Overview
Explore the profile of Ying-Nan Wang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
1849
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ruan D, Li T, Wang Y, Meng Q, Li Y, Yu K, et al.
Oncogene
. 2025 Feb;
44(8):558.
PMID: 39905122
No abstract available.
2.
Wang Y, Lu J, Wu Q, Jin Y, Wang D, Chen Y, et al.
Mol Cancer
. 2025 Jan;
24(1):31.
PMID: 39865244
No abstract available.
3.
Wang F, Jin Y, Wang M, Luo H, Fang W, Wang Y, et al.
Nat Med
. 2024 Mar;
30(4):1035-1043.
PMID: 38438735
Epigenetic modifications of chromatin, including histone acetylation, and tumor angiogenesis play pivotal roles in creating an immunosuppressive tumor microenvironment. In the randomized phase 2 CAPability-01 trial, we investigated the potential...
4.
Targeting the cholesterol-RORα/γ axis inhibits colorectal cancer progression through degrading c-myc
Wang Y, Ruan D, Wang Z, Yu K, Rong D, Liu Z, et al.
Oncogene
. 2022 Nov;
41(49):5266-5278.
PMID: 36316442
Dysregulated cholesterol metabolism is a hallmark of colorectal cancer (CRC). However, the usage of cholesterol-lowering agents seemed to have no benefit in CRC patients. In this study, we focused on...
5.
Zhao Q, Wang F, Chen Y, Chen S, Yao Y, Zeng Z, et al.
Nat Commun
. 2022 Apr;
13(1):2342.
PMID: 35487942
The genetic basis of colorectal cancer (CRC) and its clinical associations remain poorly understood due to limited samples or targeted genes in current studies. Here, we perform ultradeep whole-exome sequencing...
6.
Ruan D, Chen Y, Wei X, Wang Y, Wang Z, Wu H, et al.
Gastroenterol Rep (Oxf)
. 2021 Dec;
9(6):560-570.
PMID: 34925853
Background: Due to its limited efficacy and potential toxicity, anti-PD-1 monoclonal antibody is not suitable for all advanced gastric cancer (AGC) patients and predictive biomarkers identifying patients who can benefit...
7.
Ruan H, Zhu J, Wang Y
Arch Iran Med
. 2021 Nov;
24(9):704-705.
PMID: 34816688
No abstract available.
8.
Ruan D, Li T, Wang Y, Meng Q, Li Y, Yu K, et al.
Oncogene
. 2021 Jul;
40(33):5168-5181.
PMID: 34218271
Fat mass and obesity-associated protein (FTO), an N6-methyladenosine (mA) demethylase, participates in tumor progression and metastasis in many malignancies, but its role in colorectal cancer (CRC) is still unclear. Here,...
9.
Zeng Z, Lu J, Wang Y, Sheng H, Wang Y, Chen Z, et al.
Cancer Med
. 2021 Mar;
10(7):2423-2441.
PMID: 33666372
Background: Numerous reports on microRNAs have illustrated their role in tumor growth and metastasis. Recently, a new prognostic factor, miR-125b-2-3p, has been identified for predicting chemotherapeutic sensitivity in advanced colorectal...
10.
Zhao Q, Chen Y, Wu Q, Zhang C, Liu M, Wang Y, et al.
Clin Transl Immunology
. 2020 Oct;
9(10):e1173.
PMID: 33033616
Objectives: Although the genomic landscape of small-cell carcinoma of the oesophagus (SCCE) has been dissected, its transcriptome-level aberration and immune microenvironment status are unknown. Methods: Using ultra-deep whole transcriptome sequencing,...